http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2719842-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4655b70cbfba352025a1d2393b449e77
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D453-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D453-02
filingDate 1994-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d00ab820aec9b0bd59fa1122332585f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e647f0eb59d59b2971e29d62c720b7e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55fa0050be9f84d48709659a0aac187d
publicationDate 1995-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2719842-A1
titleOfInvention Quaternary salts of 1-azabicyclo [2.2.2] octane derivatives, their preparation and their therapeutic use.
abstract Compounds of formula (I) (CF DRAWING IN BOPI) in which X represents either an oxygen atom or an unsubstituted nitrogen atom, n = 0 to 1, R represents either a (C1 -C4) alkyl group, optionally branched, cyclic and / or substituted by three fluorine atoms, either a phenylmethyl group and Y represents either a halogen atom, preferably a bromine or iodine atom, or a 4-methylphenylsulfonyl group, or a methylsulfonyl group, in the form of racemic or optically pure mixtures. Therapeutic application.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2763067-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9850383-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2756564-A1
priorityDate 1994-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0221702-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0099789-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559213
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8002
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447566140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415708911
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457280508
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21491
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546243
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81626
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21394080
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90471849
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558214
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9266
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544759
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7527
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415773513
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454529707
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518747
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75540
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5162451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24841
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421254700
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5831
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419488112
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426060759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421183294

Total number of triples: 50.